Michael Aaron Malone

US Patent:

6410729, Jun 25, 2002

Filed:

Jun 21, 2000

Appl. No.:

09/598740

Inventors:

Ulrike D. Spohr - Boulder CO
Michael J. Malone - Boulder CO
Nathan B. Mantlo - Lafayette CO

Assignee:

Amgen Inc. - Thousand Oaks CA

International Classification:

C07D23902

US Classification:

544320, 321325, 514269, 514275

Abstract:

Selected novel substituted pyrimidine compounds are effective for prophylaxis and treatment of diseases, such as TNF-, IL-1, IL-6 and/or IL-8 mediated diseases, and other maladies, such as pain and diabetes. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving inflammation, pain, diabetes and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

US Patent:

6420385, Jul 16, 2002

Filed:

Feb 15, 2000

Appl. No.:

09/504509

Inventors:

Ulrike D. Spohr - Boulder CO
Michael J. Malone - Boulder CO
Nathan B. Mantlo - Lafayette CO
Jeffery A. Zablocki - Lafayette CO

Assignee:

Amgen Inc. - Thousand Oaks CA

International Classification:

A61K 3144

US Classification:

514310, 51425312, 514318, 514333, 514334, 514336, 544364, 546143, 546194, 5462821, 546256, 546257, 546258

Abstract:

Selected novel substituted pyrimidinone and pyridone compounds are effective for prophylaxis and treatment of diseases, such as TNF-, IL-1, IL-6 and/or IL-8 mediated diseases, and other maladies, such as pain and diabetes. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving inflammation, pain, diabetes and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

US Patent:

6610698, Aug 26, 2003

Filed:

Apr 3, 2002

Appl. No.:

10/117552

Inventors:

Ulrike D. Spohr - Boulder CO
Michael J. Malone - Boulder CO
Nathan B. Mantlo - Lafayette CO

Assignee:

Amgen, Inc. - Thousand Oaks CA

International Classification:

A61K 31505

US Classification:

514269, 514272, 514275, 544320, 544321, 544330, 544331, 544332, 544333

Abstract:

Selected novel substituted pyrimidine compounds are effective for prophylaxis and treatment of diseases, such as TNF-, IL-1, IL-6 and/or IL-8 mediated diseases, and other maladies, such as pain and diabetes. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving inflammation, pain, diabetes and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

US Patent:

6649604, Nov 18, 2003

Filed:

Apr 23, 2002

Appl. No.:

10/128271

Inventors:

Ulrike D. Spohr - Boulder CO
Michael J. Malone - Boulder CO
Nathan B. Mantlo - Lafayette CO
Jeffrey A. Zablocki - Lafayette CO

Assignee:

Amgen Inc. - Thousand Oaks CA

International Classification:

A61K 3155

US Classification:

51421402, 514221, 5142591, 5142594, 51425941, 5142595, 540568, 540578, 544279, 544281, 544282

Abstract:

Selected novel substituted pyrimidinone and pyridone compounds are effective for prophylaxis and treatment of diseases, such as TNF-, IL-1, IL-6 and/or IL-8 mediated diseases, and other maladies, such as pain and diabetes. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving inflammation, pain, diabetes and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

US Patent:

8527613, Sep 3, 2013

Filed:

Jan 26, 2010

Appl. No.:

12/693654

Inventors:

Michael William Malone - Boulder CO, US
Thad Smith - Boulder CO, US
Ryan Milbrandt - Lakewood CO, US

Assignee:

Assa Abloy AB - Stockholm

International Classification:

G06F 15/177

US Classification:

709220, 709222, 709223

Abstract:

Methods, devices, and systems are provided for remotely updating provisioning data in devices or a population of devices. An update message is generated that includes an Object Identifier (OID) that uniquely identifies eligible devices or components for the provisioning data update. If an eligible device receives the update message, then the new provisioning data is loaded on the device, thereby replacing the old provisioning data on the device.

US Patent:

20070057057, Mar 15, 2007

Filed:

Sep 7, 2006

Appl. No.:

11/470660

Inventors:

David Andresky - Lafayette CO, US
Nathan Cummings - Northglenn CO, US
Philip Clark - Kersey CO, US
Gregory Fossen - Thornton CO, US
Michael Malone - Boulder CO, US
Thad Smith - Boulder CO, US

Assignee:

ASSA ABLOY IDENTIFICATION TECHNOLOGY GROUP AB - Stockholm

International Classification:

G06K 7/08
H04Q 5/22

US Classification:

235451000, 340010100

Abstract:

Methods and apparatus for provisioning the use of multiple readers and/or wireless communication protocols within a defined area are provided. More specifically, a coordinator or the like can be used to manage the activation and deactivation of the multiple readers and/or communication protocols within a single reader such that interference between disparate technologies is avoided.

US Patent:

60967536, Aug 1, 2000

Filed:

Dec 4, 1997

Appl. No.:

8/985346

Inventors:

Ulrike D. Spohr - Boulder CO
Michael J. Malone - Boulder CO
Nathan B. Mantlo - Lafayette CO

Assignee:

Amgen Inc. - Thousand Oaks CA

International Classification:

A61K 31506
A61K 31513
A61P 1900
C07D23924

US Classification:

514269

Abstract:

Selected novel substituted pyrimidinone and pyridone compounds are effective for prophylaxis and treatment of diseases, such as TNF-. alpha. , IL-1. beta. , IL-6 and/or IL-8 mediated diseases, and other maladies, such as pain and diabetes. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving inflammation, pain, diabetes and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

US Patent:

20200342698, Oct 29, 2020

Filed:

Jul 9, 2020

Appl. No.:

16/924587

Inventors:

Hugo Wendling - Denver CO, US
Michael T. Conlin - Superior CO, US
Daniel William Field - Broomfield CO, US
Michael William Malone - Boulder CO, US
Taylor Schmidt - Littleton CO, US

International Classification:

G07C 9/00
G07C 9/30

Abstract:

Disclosed embodiments provide an integrated access control system. The integrated access control system includes both credential reader functionality and door controller functionality in the same package. In embodiments, the circuitry is miniaturized to fit within a standard “single gang” box such as those used for a standard light switch or receptacle. In this way, the integrated access control system of disclosed embodiments installs easily and unobtrusively in standard sized openings. To operate in a confined area such as a single gang box enclosure, a variety of thermal management and power management techniques are employed to provide reliable operation.